Cargando…

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD

OBJECTIVE: To evaluate the efficacy, safety, and duration of action of the once-daily extended-release methylphenidate formulation PRC-063 for the treatment of ADHD in an adult laboratory classroom (ALC). METHOD: After dose optimization with PRC-063 over 7 weeks, adults with ADHD were randomized to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Childress, Ann, Cutler, Andrew J., Marraffino, Andrea H., Bhaskar, Sailaja, Donnelly, Graeme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859679/ https://www.ncbi.nlm.nih.gov/pubmed/34189995 http://dx.doi.org/10.1177/10870547211025610

Ejemplares similares

Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD
por: Cataldo, Marc, et al.
Publicado: (2022)

Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study
por: Childress, Ann C., et al.
Publicado: (2020)

Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension
por: Weiss, Margaret D., et al.
Publicado: (2020)

Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults
por: Katzman, Martin A., et al.
Publicado: (2020)

Effect of a Multi-Layer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adults with ADHD: A Randomized, Double-Blind, Forced-Dose, Placebo-Controlled Trial Followed by a 6-month Open-Label Extension
por: Weiss, Margaret Danielle, et al.
Publicado: (2021)

Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting
por: Childress, Ann C., et al.
Publicado: (2017)

Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study
por: Wigal, Sharon B., et al.
Publicado: (2018)

Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release
por: Weiss, Margaret, et al.
Publicado: (2019)

Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study
por: Wigal, Sharon B., et al.
Publicado: (2019)

ADHD, Methylphenidate, and Childhood Epilepsy
por: Sharma, Rahul, et al.
Publicado: (2016)

Multiscale assessment of treatment efficacy in adults with ADHD: A randomized placebo-controlled, multi-centre study with extended-release methylphenidate
por: Retz, Wolfgang, et al.
Publicado: (2012)

A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings
por: Childress, Ann C., et al.
Publicado: (2020)

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
por: Bieś, Rafał, et al.
Publicado: (2023)

Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder
por: Newcorn, Jeffrey H., et al.
Publicado: (2017)

Effect of Methylphenidate on Sleep Parameters in Children with ADHD
por: Lee, Sang Heon, et al.
Publicado: (2012)

Postural Instability in Children with ADHD Is Improved by Methylphenidate
por: Bucci, Maria P., et al.
Publicado: (2016)

The Effect of Methylphenidate on Neurological Soft Signs in ADHD
por: Hrtanek, Igor, et al.
Publicado: (2015)

Effect of Methylphenidate on State Anxiety in Children With ADHD-A Single Dose, Placebo Controlled, Crossover Study
por: Kritchman, Maya, et al.
Publicado: (2019)

The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study
por: Childress, Ann C., et al.
Publicado: (2015)

Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate
por: Engert, Veronika, et al.
Publicado: (2008)

The Decrease in Human Endogenous Retrovirus-H Activity Runs in Parallel with Improvement in ADHD Symptoms in Patients Undergoing Methylphenidate Therapy
por: Chiara, Cipriani, et al.
Publicado: (2018)

Effects of methylphenidate on the ERP amplitude in youth with ADHD: A double-blind placebo-controlled cross-over EEG study
por: Rubinson, Mica, et al.
Publicado: (2019)

The influence of methylphenidate on the power spectrum of ADHD children – an MEG study
por: Wienbruch, Christian, et al.
Publicado: (2005)

Methylphenidate significantly improves declarative memory functioning of adults with ADHD
por: Verster, Joris C., et al.
Publicado: (2010)

Comorbidities in ADHD children treated with methylphenidate: a database study
por: Kraut, Angela A, et al.
Publicado: (2013)

Predicting Methylphenidate Response in ADHD Using Machine Learning Approaches
por: Kim, Jae-Won, et al.
Publicado: (2015)

Reduced pain perception in children and adolescents with ADHD is normalized by methylphenidate
por: Wolff, Nicole, et al.
Publicado: (2016)

Skin picking disorder comorbid with ADHD successfully treated with methylphenidate
por: Bernardes, Camila, et al.
Publicado: (2018)

Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD
por: D’Aiello, Barbara, et al.
Publicado: (2022)

Alpha/beta-gamma decoupling in methylphenidate medicated ADHD patients
por: Zammit, Nowell, et al.
Publicado: (2023)

Methylphenidate Efficacy: Immediate versus Extended Release at Short Term in Mexican Children with ADHD Assessed by Conners Scale and EEG
por: Durand-Rivera, Alfredo, et al.
Publicado: (2015)

Methylphenidate treatment of adult ADHD patients improves the degree of ADHD severity under routine conditions
por: Retz, Wolfgang, et al.
Publicado: (2020)

Methylphenidate Use for Emotional Dysregulation in Children and Adolescents with ADHD and ADHD and ASD: A Naturalistic Study
por: Ventura, Patrizia, et al.
Publicado: (2022)

Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage
por: Chermá, Maria D., et al.
Publicado: (2016)

Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder
por: Pliszka, Steven R., et al.
Publicado: (2017)

Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

The Four Causes of ADHD: Aristotle in the Classroom
por: Pérez-Álvarez, Marino
Publicado: (2017)

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder
por: Wigal, Sharon B., et al.
Publicado: (2017)

Pharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release
por: Roesch, Benno, et al.
Publicado: (2013)

The Effects of Methylphenidate on Goal-directed Behavior in a Rat Model of ADHD
por: Natsheh, Joman Y., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ib1ljv8k3cbrcmo6p618fgv5jm